Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Longevity | 6 | 2020 | 143 | 1.580 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 638 | 1.300 |
Why?
|
| Telomerase | 4 | 2016 | 40 | 0.660 |
Why?
|
| Leukocytes | 1 | 2018 | 68 | 0.650 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2016 | 81 | 0.630 |
Why?
|
| Telomere | 3 | 2016 | 51 | 0.570 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 271 | 0.570 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 57 | 0.470 |
Why?
|
| Signal Transduction | 1 | 2018 | 1802 | 0.350 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 31 | 0.340 |
Why?
|
| Cell Hypoxia | 3 | 2016 | 55 | 0.260 |
Why?
|
| Japan | 3 | 2020 | 296 | 0.240 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 102 | 0.210 |
Why?
|
| Coronary Disease | 1 | 2020 | 113 | 0.180 |
Why?
|
| Genotype | 2 | 2018 | 641 | 0.170 |
Why?
|
| Heterozygote | 1 | 2018 | 91 | 0.170 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 2333 | 0.160 |
Why?
|
| Hydra | 1 | 2018 | 4 | 0.160 |
Why?
|
| Alleles | 1 | 2018 | 284 | 0.160 |
Why?
|
| Sirtuin 3 | 1 | 2016 | 5 | 0.150 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2016 | 7 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 32 | 0.150 |
Why?
|
| Pre-Eclampsia | 1 | 2016 | 57 | 0.140 |
Why?
|
| Animals | 6 | 2018 | 14307 | 0.140 |
Why?
|
| Encephalitis | 1 | 2016 | 39 | 0.140 |
Why?
|
| Germ Cells | 1 | 2016 | 70 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 147 | 0.140 |
Why?
|
| Mice | 5 | 2016 | 5668 | 0.130 |
Why?
|
| Transfection | 1 | 2016 | 496 | 0.130 |
Why?
|
| Stem Cells | 1 | 2016 | 132 | 0.130 |
Why?
|
| Monocytes | 1 | 2016 | 258 | 0.120 |
Why?
|
| Humans | 8 | 2020 | 34853 | 0.120 |
Why?
|
| Hypertension | 1 | 2020 | 770 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 592 | 0.120 |
Why?
|
| Aged | 3 | 2020 | 6448 | 0.110 |
Why?
|
| Aging | 1 | 2018 | 639 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2016 | 294 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 2561 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2011 | 52 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 161 | 0.090 |
Why?
|
| Male | 5 | 2020 | 18870 | 0.090 |
Why?
|
| RNA Interference | 1 | 2010 | 225 | 0.090 |
Why?
|
| Young Adult | 1 | 2018 | 4012 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 484 | 0.080 |
Why?
|
| Middle Aged | 2 | 2018 | 9642 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 550 | 0.080 |
Why?
|
| Female | 4 | 2018 | 19873 | 0.070 |
Why?
|
| Adult | 2 | 2018 | 11034 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2009 | 897 | 0.070 |
Why?
|
| Models, Biological | 1 | 2009 | 642 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1149 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 968 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 1530 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 650 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 727 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 841 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1056 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 528 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 1007 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 859 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 430 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 10 | 0.040 |
Why?
|
| Trophoblasts | 1 | 2016 | 22 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 455 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 48 | 0.040 |
Why?
|
| Placenta | 1 | 2016 | 91 | 0.040 |
Why?
|
| Ovum | 1 | 2016 | 31 | 0.040 |
Why?
|
| Gestational Age | 1 | 2016 | 190 | 0.040 |
Why?
|
| Prevalence | 1 | 2020 | 1425 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 185 | 0.030 |
Why?
|
| Ovary | 1 | 2016 | 101 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 200 | 0.030 |
Why?
|
| Testis | 1 | 2016 | 185 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 153 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 605 | 0.030 |
Why?
|
| Hawaii | 1 | 2020 | 1878 | 0.030 |
Why?
|
| Spermatozoa | 1 | 2016 | 191 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 834 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 1353 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2016 | 562 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 569 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 1503 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1152 | 0.030 |
Why?
|
| Homeostasis | 1 | 2010 | 172 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 3414 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 932 | 0.020 |
Why?
|
| United States | 1 | 2017 | 3894 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1490 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1289 | 0.020 |
Why?
|